{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Oswego",
      "state": "OR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91694",
      "recalling_firm": "HTO Nevada, Inc.",
      "address_1": "6400 Rosewood St",
      "address_2": "N/A",
      "postal_code": "97035-5392",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA and Canada.",
      "recall_number": "D-0270-2023",
      "product_description": "New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive procedures, 1 oz bottle, distributed by Dermal Source, Portland, OR, www.dermalsource.com 1-888-568-3223. NDC Code: 80069-008-01. Drug Facts- For use by licensed professionals only, Active Ingredients -Lidocaine HCL (5%), Tetracaine HCL (1%) and epinephrine (0.1%).",
      "product_quantity": "4709 bottles",
      "reason_for_recall": "cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.",
      "recall_initiation_date": "20230209",
      "center_classification_date": "20230215",
      "termination_date": "20231117",
      "report_date": "20230222",
      "code_info": "Lot #s: 796CP-0006, Exp 02/2024; 796CP-0007, Exp 03/2024."
    }
  ]
}